Sun Pharma was at lifetime high yesterday at Rs 854. It has received final approval for Novartis's Reclast/Aclasta, which is used in the treatment of osteoporosis.
first published: Apr 3, 2013 03:12 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

